Vega Masignani

13.8k total citations · 1 hit paper
66 papers, 4.8k citations indexed

About

Vega Masignani is a scholar working on Epidemiology, Microbiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Vega Masignani has authored 66 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 42 papers in Microbiology and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Vega Masignani's work include Pneumonia and Respiratory Infections (42 papers), Bacterial Infections and Vaccines (42 papers) and Streptococcal Infections and Treatments (18 papers). Vega Masignani is often cited by papers focused on Pneumonia and Respiratory Infections (42 papers), Bacterial Infections and Vaccines (42 papers) and Streptococcal Infections and Treatments (18 papers). Vega Masignani collaborates with scholars based in Italy, United States and United Kingdom. Vega Masignani's co-authors include Rino Rappuoli, Mariagrazia Pizza, Claudio Donati, Hervé Tettelin, Duccio Medini, Michèle A. Barocchi, Beatrice Aricò, Antonello Covacci, Maurizio Comanducci and Jeannette Adu‐Bobie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Vega Masignani

66 papers receiving 4.6k citations

Hit Papers

The microbial pan-genome 2005 2026 2012 2019 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vega Masignani Italy 32 2.1k 2.0k 1.8k 885 814 66 4.8k
Ian M. Feavers United Kingdom 37 3.4k 1.6× 3.9k 2.0× 2.0k 1.1× 589 0.7× 980 1.2× 113 7.2k
Janet Yother United States 35 2.7k 1.3× 1.3k 0.6× 1.1k 0.6× 1.1k 1.2× 436 0.5× 53 4.2k
J. Simon Kroll United Kingdom 36 1.7k 0.8× 2.4k 1.2× 1.2k 0.7× 282 0.3× 449 0.6× 84 4.6k
Davide Serruto Italy 29 1.5k 0.7× 1.7k 0.9× 1.2k 0.6× 257 0.3× 657 0.8× 43 3.6k
Jean‐Pierre Claverys France 42 2.4k 1.2× 1.2k 0.6× 2.4k 1.3× 1.0k 1.1× 731 0.9× 71 5.5k
Kate L. Seib Australia 35 1.2k 0.6× 1.8k 0.9× 1.3k 0.7× 240 0.3× 414 0.5× 98 3.4k
Anthony B. Schryvers Canada 39 704 0.3× 1.6k 0.8× 1.2k 0.7× 417 0.5× 524 0.6× 126 3.9k
Loek van Alphen Netherlands 37 1.8k 0.9× 2.1k 1.1× 2.4k 1.3× 400 0.5× 449 0.6× 90 6.1k
Eric T. Harvill United States 37 1.6k 0.8× 2.5k 1.2× 1.2k 0.6× 243 0.3× 580 0.7× 142 4.2k
E. Richard Moxon United Kingdom 47 3.1k 1.5× 3.8k 1.9× 2.2k 1.2× 409 0.5× 457 0.6× 116 6.7k

Countries citing papers authored by Vega Masignani

Since Specialization
Citations

This map shows the geographic impact of Vega Masignani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vega Masignani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vega Masignani more than expected).

Fields of papers citing papers by Vega Masignani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vega Masignani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vega Masignani. The network helps show where Vega Masignani may publish in the future.

Co-authorship network of co-authors of Vega Masignani

This figure shows the co-authorship network connecting the top 25 collaborators of Vega Masignani. A scholar is included among the top collaborators of Vega Masignani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vega Masignani. Vega Masignani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borrow, Ray, Daniela Toneatto, Stefania Bambini, et al.. (2025). Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccine. mSphere. 10(4). e0089824–e0089824. 1 indexed citations
2.
Giuliani, Maria Elisa, Fabiola Giusti, Roberto Melero, et al.. (2019). Structural basis for cooperativity of human monoclonal antibodies to meningococcal factor H-binding protein. Communications Biology. 2(1). 241–241. 7 indexed citations
3.
Bianchi, Federica, Daniele Veggi, Laura Santini, et al.. (2019). Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6. The FASEB Journal. 33(11). 12099–12111. 3 indexed citations
4.
Rappuoli, Rino, Mariagrazia Pizza, Vega Masignani, & Kumaran Vadivelu. (2018). Meningococcal B vaccine (4CMenB): the journey from research to real world experience. Expert Review of Vaccines. 17(12). 1111–1121. 68 indexed citations
5.
Domina, Maria, Veronica Lanza Cariccio, Salvatore Benfatto, et al.. (2016). Functional characterization of a monoclonal antibody epitope using a lambda phage display-deep sequencing platform. Scientific Reports. 6(1). 31458–31458. 9 indexed citations
6.
Vacca, Irene, Elena Del Tordello, Gianmarco Gasperini, et al.. (2016). Neisserial Heparin Binding Antigen (NHBA) Contributes to the Adhesion of Neisseria meningitidis to Human Epithelial Cells. PLoS ONE. 11(10). e0162878–e0162878. 37 indexed citations
7.
Valeri, María Cristina, Danilo Donnarumma, Silvia Maccari, et al.. (2015). Identification of a Monoclonal Antibody Against Pneumococcal Pilus 1 Ancillary Protein Impairing Bacterial Adhesion to Human Epithelial Cells. The Journal of Infectious Diseases. 213(4). 516–522. 12 indexed citations
8.
Ahmed, Muhammad S., Brian Flanagan, Christopher Loh, et al.. (2014). Immune responses to pneumococcal pilus RrgA and RrgB antigens and their relationship with pneumococcal carriage in humans. Journal of Infection. 68(6). 562–571. 13 indexed citations
9.
Moschioni, Monica, Gabriella De Angelis, Vega Masignani, et al.. (2010). Prevalence of pilus-encoding islets among acute otitis media Streptococcus pneumoniae isolates from Israel. Clinical Microbiology and Infection. 16(9). 1501–1504. 21 indexed citations
10.
Spraggon, Glen, Eric Koesema, Maria Scarselli, et al.. (2010). Supramolecular Organization of the Repetitive Backbone Unit of the Streptococcus pneumoniae Pilus. PLoS ONE. 5(6). e10919–e10919. 49 indexed citations
11.
Moschioni, Monica, Gabriella De Angelis, Vega Masignani, et al.. (2009). Prevalence of pilus encoding islets among acute otitis mediaStreptococcus pneumoniaeisolates from Israel.. Clinical Microbiology and Infection. 16(9). 1501–4. 25 indexed citations
12.
Serruto, Davide, Tiziana Spadafina, Maria Scarselli, et al.. (2009). HadA is an atypical new multifunctional trimeric coiled-coil adhesin ofHaemophilus influenzaebiogroupaegyptius, which promotes entry into host cells. Cellular Microbiology. 11(7). 1044–1063. 28 indexed citations
13.
Serruto, Davide, Laura Serino, Vega Masignani, & Mariagrazia Pizza. (2009). Genome-based approaches to develop vaccines against bacterial pathogens. Vaccine. 27(25-26). 3245–3250. 57 indexed citations
14.
Hilleringmann, Markus, Fabiola Giusti, Barbara C. Baudner, et al.. (2008). Pneumococcal Pili Are Composed of Protofilaments Exposing Adhesive Clusters of Rrg A. PLoS Pathogens. 4(3). e1000026–e1000026. 105 indexed citations
15.
Moriel, Danilo Gomes, Maria Scarselli, Laura Serino, et al.. (2008). Genome‑based vaccine development: A short cut for the future. Human Vaccines. 4(3). 184–188. 34 indexed citations
16.
Barocchi, Michèle A., Xhavit Zogaj, Carolyn Hemsley, et al.. (2006). A pneumococcal pilus influences virulence and host inflammatory responses. Proceedings of the National Academy of Sciences. 103(8). 2857–2862. 350 indexed citations
17.
Tettelin, Hervé, Duccio Medini, Claudio Donati, & Vega Masignani. (2006). Towards a universal group BStreptococcusvaccine using multistrain genome analysis. Expert Review of Vaccines. 5(5). 687–694. 19 indexed citations
18.
Serruto, Davide, Jeannette Adu‐Bobie, Barbara Capecchi, et al.. (2004). Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens. Journal of Biotechnology. 113(1-3). 15–32. 40 indexed citations
19.
Stadler, Konrad, Vega Masignani, Markus Eickmann, et al.. (2003). SARS — beginning to understand a new virus. Nature Reviews Microbiology. 1(3). 209–218. 396 indexed citations
20.
Masignani, Vega, Rino Rappuoli, & Mariagrazia Pizza. (2002). Reverse vaccinology: a genome-based approach for vaccine development. Expert Opinion on Biological Therapy. 2(8). 895–905. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026